OR WAIT null SECS
September 02, 2009
Select contract manufacturing organizations roll out expansions for production of active pharmaceutical ingredients and intermediates.
August 02, 2009
Biologics enhance their positions amidst slowing growth in the global and US markets.
July 02, 2009
High-potency manufacturing of active pharmaceutical ingredients is a growing and specialized capability.
March 02, 2009
Contract manufacturers deploy a business model using operations in the US and Western Europe with facilities in Asia.
February 02, 2009
The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry.
January 02, 2009
Catalysis for olefin metathesis and aldol reactions and synthetic routes to natural products are some recent gains.
December 02, 2008
A recent Pharmaceutical Technology survey examined the level, sources, and reasons behind innovation in drug development and manufacturing. This article contains bonus online-exclusive material.
November 02, 2008
Optimizing the solid form of a drug reaps scientific and technical awards.
October 02, 2008
Emerging pharmaceutical companies represent an important client base for CROs and CMOs. Lessons learned for successful customer–supplier relations.
September 02, 2008
Carbon–hydrogen functionalization, ketone α-alkylation, and biocatalysis are some recent advances in asymmetric synthesis.